BioSig Technologies, Inc. STEX Debt Instrument Convertible Conversion Price
Debt Instrument Convertible Conversion Price at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtInstrumentConvertibleConversionPrice1.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s debt instrument convertible conversion price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s debt instrument convertible conversion price?
- BioSig Technologies, Inc. (STEX) reported debt instrument convertible conversion price of $6.02 in Q1 2026.
- What does debt instrument convertible conversion price mean?
- The predetermined price at which convertible debt holders can exchange their debt for equity shares. This metric is essential for assessing the potential for future equity dilution and the company's cost of financing.